{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:30:13Z","timestamp":1769812213009,"version":"3.49.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"UNDP\/World Bank\/WHO Special Programme"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Non-ionic-surfactant vesicular (NIV) formulations of paromomycin have been tested in-vitro and in-vivo for their activity against Leishmania donovani.<\/jats:p>\n               <jats:p>Production of NIV was dependent both on the surfactant used and on the concentration of paromomycin; only two of the surfactants studied formed vesicles at the highest paromomycin concentration (9mg mL\u22121). At surfactant-lipid concentrations.1.5mM, suspensions of NIV (drug- or glucose-loaded) were cytotoxic to macrophages infected with L. donovani; high levels of nitrite were produced in cell supernatants. At surfactant-lipid concentrations &amp;lt; 1.5 mM, drug-loaded NIV were more effective than the same dose of free drug, in terms of the percentage of cells infected and the number of parasites\/cell. At surfactant-lipid concentrations.0.15mM, drug-loaded NIV were ineffective in-vitro. Invivo, treatment with decaethylene glycol mono n-hexadecyl ether paromomycin NIV was more effective than hexaethylene glycol mono n-hexadecyl ether paromomycin NIV, in terms of suppression of liver and spleen parasite burdens. Against liver parasites, both types of paromomycin-loaded NIV were more effective than free drug. Neither the NIV nor free forms of paromomycin caused significant suppression of bone-marrow parasites.<\/jats:p>\n               <jats:p>The study shows that entrapment of paromomycin in NIV can be used to increase its antileishmanial activity in-vitro and in-vivo.<\/jats:p>","DOI":"10.1111\/j.2042-7158.1998.tb03358.x","type":"journal-article","created":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T15:40:19Z","timestamp":1302709219000},"page":"1351-1356","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of the Efficacy of Free and Non-ionic-surfactant Vesicular Formulations of Paromomycin in a Murine Model of Visceral Leishmaniasis"],"prefix":"10.1093","volume":"50","author":[{"given":"D","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Immunology, University of Strathclyde , Glasgow,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A B","family":"Mullen","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Strathclyde , Glasgow,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Baillie","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and, University of Strathclyde , Glasgow,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K C","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Strathclyde , Glasgow,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1998,12,1]]},"reference":[{"key":"2024103110022351900_cit1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/excr.1994.1187","article-title":"Interleukin-1 \u03b2-induced nitric oxide production activates apoptosis in pancreatic RINm5F cell","volume":"213","author":"Ankarcrona","year":"1994","journal-title":"Exp. Cell Res."},{"key":"2024103110022351900_cit2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.2042-7158.1987.tb05126.x","article-title":"Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate","volume":"39","author":"Baillie","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110022351900_cit3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"2024103110022351900_cit4","first-page":"119","article-title":"Regulation of Leishmania populations within the host. I The variable course of Leishmania donovani infections in mice","volume":"30","author":"Bradley","year":"1977","journal-title":"Clin. Exp. Immunol."},{"key":"2024103110022351900_cit5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.2042-7158.1988.tb05271.x","article-title":"The therapeutic effect of sodium stibogluconate in BALB\/c mice infected with Leishmania donovani is organ-dependent","volume":"40","author":"Carter","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110022351900_cit6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jps.2600820405","article-title":"Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions","volume":"82","author":"Grit","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"2024103110022351900_cit7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.2042-7158.1993.tb05585.x","article-title":"Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics","volume":"45","author":"Grit","year":"1993","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110022351900_cit8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.316.7139.1200","article-title":"Randomized controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India","volume":"316","author":"Jha","year":"1998","journal-title":"Br. Med. J."},{"key":"2024103110022351900_cit9","first-page":"139","article-title":"Lipid peroxidation in liposomes","volume-title":"Liposome Technology","author":"Konings","year":"1984","edition":"1st edn"},{"key":"2024103110022351900_cit10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/AAC.41.10.2089","article-title":"A comparison of the efficacy of various formulations of amphotericin B against murine visceral leishmaniasis","volume":"41","author":"Mullen","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024103110022351900_cit11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxant factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"2024103110022351900_cit12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0035-9203(92)90150-B","article-title":"Treatment of visceral leishmaniasis (kala-azar) with aminosidine (paromomycin)-antimonial combinations, a pilot study in Bihar, India","volume":"86","author":"Thakur","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"2024103110022351900_cit13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00002018-199513040-00001","article-title":"Formulations of Amphotericin B","volume":"13","author":"Tollemar","year":"1995","journal-title":"Drug Safety"},{"key":"2024103110022351900_cit14","first-page":"465","article-title":"Activated endothelial cells induce apoptosis in lymphoma cells: role of nitric oxide","volume":"10","author":"Umansky","year":"1997","journal-title":"Int. J. Oncol."},{"key":"2024103110022351900_cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10611869509015926","article-title":"Visceral leishmaniasis in the BALB\/c mouse: a comparison of the in vivo activity of five non-ionic surfactant vesicle preparations of sodium stibogluconate","volume":"3","author":"Williams","year":"1995","journal-title":"J. Drug Targeting"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.1998.tb03358.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/50\/12\/1351\/60262011\/j.2042-7158.1998.tb03358.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/50\/12\/1351\/60262011\/j.2042-7158.1998.tb03358.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:32:30Z","timestamp":1730370750000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/50\/12\/1351\/6152790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12,1]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[1998,12,1]]},"published-print":{"date-parts":[[1998,12,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.1998.tb03358.x","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"value":"2042-7158","type":"electronic"},{"value":"0022-3573","type":"print"}],"subject":[],"published-other":{"date-parts":[[1998,12]]},"published":{"date-parts":[[1998,12,1]]}}}